- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x ZN: ZINC ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 15 x IOD: IODIDE ION(Non-functional Binders)
IOD.5: 7 residues within 4Å:- Chain A: K.153, G.174, N.175, S.176, V.330, L.334, R.336
Ligand excluded by PLIPIOD.6: 4 residues within 4Å:- Chain A: F.570, R.691, T.693, E.694
Ligand excluded by PLIPIOD.9: 3 residues within 4Å:- Chain A: K.401, P.402, L.403
Ligand excluded by PLIPIOD.32: 5 residues within 4Å:- Chain A: C.52, G.53, E.66, Y.78, C.82
Ligand excluded by PLIPIOD.36: 4 residues within 4Å:- Chain A: P.144, K.444, P.446, P.447
Ligand excluded by PLIPIOD.37: 6 residues within 4Å:- Chain A: P.732, L.733, R.788, E.792, I.793, L.796
Ligand excluded by PLIPIOD.39: 6 residues within 4Å:- Chain A: T.579, S.581, G.674, P.725, A.726, D.727
Ligand excluded by PLIPIOD.45: 4 residues within 4Å:- Chain A: R.394, K.424, V.425, E.804
Ligand excluded by PLIPIOD.46: 6 residues within 4Å:- Chain A: P.331, G.332, H.397, V.398, A.399
- Ligands: SCN.10
Ligand excluded by PLIPIOD.47: 2 residues within 4Å:- Chain A: R.189, G.190
Ligand excluded by PLIPIOD.48: 5 residues within 4Å:- Chain A: F.507, L.509, G.510, C.511, P.599
Ligand excluded by PLIPIOD.53: 6 residues within 4Å:- Chain A: S.176, M.177, Y.178, H.187, V.330, R.338
Ligand excluded by PLIPIOD.54: 3 residues within 4Å:- Chain A: H.142, P.144, K.444
Ligand excluded by PLIPIOD.55: 5 residues within 4Å:- Chain A: K.25, S.26, S.221, V.222, S.223
Ligand excluded by PLIPIOD.56: 5 residues within 4Å:- Chain A: H.226, F.250, S.252, I.276, T.279
Ligand excluded by PLIP- 1 x 01: N-(3-(3-((4-(4-fluorophenyl)thiazol-2-yl)(methyl)amino)-6-(1-(methylsulfonyl)piperidin-4-yl)imidazo[1,2-b]pyridazin-2-yl)propyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-carboxamide
01.7: 32 residues within 4Å:- Chain A: I.112, D.116, K.153, T.154, F.155, L.158, Y.159, L.161, A.162, N.175, L.188, K.193, F.194, H.196, W.199, P.203, W.205, F.218, F.219, A.249, Y.251, E.253, D.256, H.260, H.304, H.419, M.457
- Ligands: ZN.2, ZN.3, SCN.30, SCN.57, SCN.59
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:I.112, A:T.154, A:F.155, A:L.158, A:L.161, A:A.162, A:L.188, A:K.193, A:F.194, A:W.199, A:F.218, A:A.249
- Hydrogen bonds: A:N.175, A:W.205, A:Y.251, A:D.256, A:H.260, A:H.419
- Water bridges: A:K.153, A:K.153
- 30 x SCN: THIOCYANATE ION(Non-functional Binders)
SCN.8: 5 residues within 4Å:- Chain A: Q.619, Y.650, P.651, A.652, P.744
Ligand excluded by PLIPSCN.10: 7 residues within 4Å:- Chain A: L.329, P.331, A.399, R.400, D.404
- Ligands: SCN.11, IOD.46
Ligand excluded by PLIPSCN.11: 6 residues within 4Å:- Chain A: T.328, L.329, P.331, K.340, R.400
- Ligands: SCN.10
Ligand excluded by PLIPSCN.12: 4 residues within 4Å:- Chain A: Y.178, R.338, A.339, S.341
Ligand excluded by PLIPSCN.13: 4 residues within 4Å:- Chain A: A.184, S.185, E.192, R.197
Ligand excluded by PLIPSCN.14: 4 residues within 4Å:- Chain A: Q.254, N.271, P.272, E.275
Ligand excluded by PLIPSCN.15: 8 residues within 4Å:- Chain A: K.40, N.60, A.61, C.62, H.63, D.73, R.228, Q.235
Ligand excluded by PLIPSCN.16: 6 residues within 4Å:- Chain A: C.7, F.8, T.232, Q.235, W.236, L.239
Ligand excluded by PLIPSCN.17: 6 residues within 4Å:- Chain A: G.623, F.624, Y.629, W.657, A.658, Q.661
Ligand excluded by PLIPSCN.18: 7 residues within 4Å:- Chain A: C.358, N.746, D.747, S.749, C.750, S.752, S.753
Ligand excluded by PLIPSCN.19: 5 residues within 4Å:- Chain A: G.171, N.382, R.383, R.384
- Ligands: NAG-NAG-BMA-MAN-MAN.1
Ligand excluded by PLIPSCN.20: 5 residues within 4Å:- Chain A: S.176, H.187, L.329, V.330, P.331
Ligand excluded by PLIPSCN.21: 7 residues within 4Å:- Chain A: L.542, Y.543, A.726, D.727, K.728, C.729, L.733
Ligand excluded by PLIPSCN.22: 3 residues within 4Å:- Chain A: E.538, R.539, D.727
Ligand excluded by PLIPSCN.23: 5 residues within 4Å:- Chain A: R.19, L.23, S.26, S.28, F.194
Ligand excluded by PLIPSCN.27: 2 residues within 4Å:- Chain A: D.91, D.92
Ligand excluded by PLIPSCN.29: 7 residues within 4Å:- Chain A: D.617, K.618, Q.619, M.620, S.621, P.651
- Ligands: GOL.40
Ligand excluded by PLIPSCN.30: 4 residues within 4Å:- Chain A: L.23, F.194, H.196
- Ligands: 01.7
Ligand excluded by PLIPSCN.33: 7 residues within 4Å:- Chain A: S.736, S.737, F.738, M.764, K.765, T.768, Y.803
Ligand excluded by PLIPSCN.34: 6 residues within 4Å:- Chain A: S.757, K.758, W.759, V.760, E.761, E.762
Ligand excluded by PLIPSCN.35: 3 residues within 4Å:- Chain A: E.85, S.86, K.288
Ligand excluded by PLIPSCN.41: 4 residues within 4Å:- Chain A: L.549, Y.550, R.691, G.779
Ligand excluded by PLIPSCN.42: 2 residues within 4Å:- Chain A: R.545, R.784
Ligand excluded by PLIPSCN.43: 7 residues within 4Å:- Chain A: L.571, S.608, Q.609, N.610, S.704, S.705, I.706
Ligand excluded by PLIPSCN.44: 6 residues within 4Å:- Chain A: P.180, K.370, R.383, I.385, E.386, D.387
Ligand excluded by PLIPSCN.50: 3 residues within 4Å:- Chain A: I.206, T.209, K.210
Ligand excluded by PLIPSCN.51: 6 residues within 4Å:- Chain A: N.476, R.485, P.486, S.789, Y.790, S.791
Ligand excluded by PLIPSCN.52: 8 residues within 4Å:- Chain A: H.372, Y.650, Y.685, V.708, P.709, T.710, H.742, R.743
Ligand excluded by PLIPSCN.57: 8 residues within 4Å:- Chain A: Y.159, H.196, W.199, G.201, Q.202, P.203, I.206
- Ligands: 01.7
Ligand excluded by PLIPSCN.59: 6 residues within 4Å:- Chain A: F.218, F.219, W.220, R.229, Y.251
- Ligands: 01.7
Ligand excluded by PLIP- 9 x GOL: GLYCEROL(Non-functional Binders)
GOL.24: 9 residues within 4Å:- Chain A: I.353, T.357, K.366, P.367, Y.368, M.369, H.372, D.747, E.748
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.357
GOL.25: 13 residues within 4Å:- Chain A: E.452, N.455, V.456, D.459, T.471, H.472, G.473, S.474, L.475, N.476, L.479, N.482, F.484
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:T.471, A:G.473, A:S.474, A:L.475, A:L.475, A:L.475
- Water bridges: A:N.455
GOL.26: 9 residues within 4Å:- Chain A: W.88, D.91, D.92, C.93, E.94, K.135, H.293, R.294, Y.435
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:D.92, A:E.94, A:R.294, A:Y.435
- Water bridges: A:W.88, A:E.94, A:Y.435
GOL.28: 11 residues within 4Å:- Chain A: G.72, D.73, C.74, T.76, L.231, L.234, Q.235, S.238, G.286, Q.289, L.290
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.235, A:G.286, A:Q.289
- Water bridges: A:G.72, A:C.74
GOL.31: 6 residues within 4Å:- Chain A: P.99, C.101, F.105, V.106, R.107, P.108
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.107
GOL.38: 8 residues within 4Å:- Chain A: N.455, P.465, A.466, P.467, N.468, G.470, T.471, H.472
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.455, A:N.468, A:G.470, A:H.472, A:H.472
GOL.40: 7 residues within 4Å:- Chain A: Y.614, K.615, M.620, S.621, Y.622, K.654
- Ligands: SCN.29
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.621, A:S.621
- Water bridges: A:Y.614, A:D.617
GOL.49: 6 residues within 4Å:- Chain A: W.205, A.215, G.216, T.217, F.218, F.219
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:G.216, A:F.218
- Water bridges: A:W.205, A:T.209
GOL.58: 8 residues within 4Å:- Chain A: S.26, Y.27, R.189, G.190, K.193, F.194, S.221, V.222
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.27, A:K.193, A:V.222
- Water bridges: A:S.26
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Desroy, N. et al., Design, Synthesis, and Biological Implications of Autotaxin inhibitors with a Three-Point lock binding mode. Bioorg.Med.Chem. (2025)
- Release Date
- 2025-04-23
- Peptides
- Isoform 2 of Autotaxin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x ZN: ZINC ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 15 x IOD: IODIDE ION(Non-functional Binders)
- 1 x 01: N-(3-(3-((4-(4-fluorophenyl)thiazol-2-yl)(methyl)amino)-6-(1-(methylsulfonyl)piperidin-4-yl)imidazo[1,2-b]pyridazin-2-yl)propyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-carboxamide
- 30 x SCN: THIOCYANATE ION(Non-functional Binders)
- 9 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Desroy, N. et al., Design, Synthesis, and Biological Implications of Autotaxin inhibitors with a Three-Point lock binding mode. Bioorg.Med.Chem. (2025)
- Release Date
- 2025-04-23
- Peptides
- Isoform 2 of Autotaxin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A